A traceability method for electronic data of first-time drug sales based on shared transmission

Abstract

The present invention provides a traceability method for electronic data of the first sale of drugs based on shared transmission, which relates to the technical field of drug platforms and includes the following steps: constructing an electronic data sharing service platform; providing authentication services for production enterprises, intermediate wholesale enterprises, and downstream enterprises to perform authentication and login, and create files; generating a traceability sharing channel on the production enterprise service page for uploading first-sale variety data; accessing a big data retrieval platform and an official website of a drug regulatory unit to review the uploaded first-sale variety data, which is displayed in the database of the electronic data sharing service platform after review; the present invention constructs an electronic data sharing service platform, and the traceability first-sale variety data uploaded by the production enterprise can be traced and shared on the platform, and after authentication, the intermediate wholesale enterprises and downstream enterprises can obtain the source first-sale variety data through traceability sharing, which further enhances the authenticity, reliability and accuracy of the information in the first-sale data.

Description

Technical Field

[0001] The present invention relates to the field of pharmaceutical platform technology, and in particular to a method for tracing the origin of pharmaceutical first-sale electronic data based on shared transmission. Background Art

[0002] In the process of drug circulation, pharmaceutical manufacturers, wholesale enterprises, retailers and medical institutions generally use paper first-time business information. During the circulation process, paper first-time business information has high production costs, long exchange cycles, difficult storage and management, difficult to distinguish authenticity, and low verification efficiency. Some paperless platforms can only be used as storage information management platforms, and cannot realize product information traceability management and audit mechanisms, and it is difficult to ensure the accuracy of the information. Therefore, the present invention proposes a traceability method for electronic first-time business information of drugs based on shared transmission to solve the problems existing in the prior art. Summary of the invention

[0003] In response to the above problems, the present invention proposes a traceability method for the first-sale electronic data of drugs based on shared transmission. The traceability method for the first-sale electronic data of drugs based on shared transmission is based on the traceability first-sale variety data uploaded by the manufacturer. After certification by the intermediate wholesale enterprises and downstream enterprises, the first-sale variety data at the source can be obtained through traceability sharing, thereby further enhancing the authenticity, reliability and accuracy of the first-sale information.

[0004] To achieve the purpose of the present invention, the present invention is implemented by the following technical scheme: a method for tracing the source of the first-time electronic data of a drug based on shared transmission, comprising the following steps:

[0005] S1: Build an electronic data sharing service platform;

[0006] S2: Provide authentication services for manufacturers, intermediate wholesalers, and downstream enterprises to log in for authentication and create files;

[0007] S3: Generate a traceability sharing channel on the production enterprise service page to upload the first-time product information;

[0008] S4: Access the big data search platform and the official website of the drug regulatory agency to review the uploaded first-time product information, which will be displayed in the database of the electronic information sharing service platform after review;

[0009] S5: Intermediate wholesalers and downstream enterprises submit drug information review applications on the platform, and the platform reviews the qualifications of drug demanders and suppliers, as well as the legality of the reviewed drug varieties;

[0010] S6: After the review is passed, the data of the first-time drug products will be shared according to the drug products reviewed, providing a channel for tracing the source for intermediate wholesale enterprises and downstream enterprises;

[0011] S7: Synchronously open the access channel, store the access records between each level of enterprises in the archive, and provide timestamp query function;

[0012] S8: When the manufacturer makes adjustments to the first-time product data, the platform reviews the adjustment operations, stores the operation records in the corresponding first-time product data, and provides a timestamp query function.

[0013] A further improvement is that: S1 comprises the following steps:

[0014] S11: Springboot+Dubbo+Nacos+Mybatis Plus is used to establish server-side feedback. Java 1.8 is used as the server-side development language and version, Maven is used as the build tool, Git is used as the version control tool, Tapd is used as the project management tool, XxlJob is used as the scheduled task scheduler, Redis is used as the remote data structure service, Alibaba Cloud OCR is used for text recognition, and NetCert CA is used for electronic certification;

[0015] S12: Use HTML5+CSS3+TypeScript to build the front-end interface, using Vue 3.0 as the web framework, Vue CLI as the building tool, Vue Router to configure page routing, Vuex to manage the status of the electronic data sharing service platform, Element Plus component library to build the user interface, Axios to send asynchronous requests, Sass to write CSS styles, and ESLint to check the code for specifications;

[0016] S13: Integrate the review channels of drug regulatory units, quality management departments, and centralized pharmaceutical distribution platforms to build login channels for manufacturers, intermediate wholesalers, and downstream companies;

[0017] S14: Build a MySQL database, and use the MySQL database to reflect the relationship between data for data interaction;

[0018] S15: Access the search engine and deploy it using the ElasticSearch+Logstash+Kibana framework. Use the ElasticSearch search server to complete a distributed multi-user full-text search engine, perform data management, and provide log analysis and visualization platforms.

[0019] A further improvement is that: S2 comprises the following steps:

[0020] S21: Build a certification review channel on the electronic data sharing service platform and connect to the review channels of drug regulatory units and quality management departments;

[0021] S22: Review the legal qualifications of production enterprises, intermediate wholesale enterprises, and downstream enterprises, and certify them as independent accounts after passing the review;

[0022] S23: Files are created based on independent accounts to store a series of circulation records of production enterprises, intermediate wholesale enterprises, and downstream enterprises.

[0023] A further improvement is that in the S3, in the process of uploading the first-time product information, text data upload and image retrieval upload functions are provided. The image retrieval upload function is based on the TF-IDF statistical document retrieval algorithm, which obtains the visual features of the image through CNN, obtains the sequence features of the image through RNN, obtains the text sequence information through the classifier CTC or the decoder attention, extracts the document in the image, and then based on the document extraction module, uses the TF-IDF statistical document retrieval algorithm to evaluate the importance of multiple words to the document, and extracts the keywords of the document as the summary words of the first-time product information.

[0024] A further improvement is that: said S4 comprises the following steps:

[0025] S41: Access to the big data search platform and the official website of the drug regulatory agency, and the platform obtains standard data based on the first-marketed product;

[0026] S42: Compare the uploaded first-time product data with standard data to review the legality and accuracy;

[0027] S43: After passing the review, it will be displayed in the database of the electronic data sharing service platform. If it fails the review, it will be rejected to the production enterprise service page, reminding the production enterprise to make revisions for the review.

[0028] A further improvement is that: S5 comprises the following steps:

[0029] S51: The management departments of the intermediate wholesale enterprises and downstream enterprises submit drug information access applications on the platform;

[0030] S52: The quality manager of the corresponding enterprise accesses the platform to review the drug information review application, and uploads the drug information review application to the review department of the platform after passing the review;

[0031] S53: The platform conducts a legality review on the types of drug information review applications, as well as a review on the legal qualifications of suppliers and drug demanders.

[0032] A further improvement is that: S6 comprises the following steps:

[0033] S61: After the review is passed, a review notice letter will be sent to the supplier, and a quality assurance agreement signing template will be provided;

[0034] S62: Then, according to the drug varieties consulted, the data sharing of first-time drug varieties is opened, providing a channel for query by intermediate wholesale enterprises and downstream enterprises;

[0035] S63: Block the authority of intermediate wholesale enterprises and downstream enterprises to modify and adjust the information of first-selling products.

[0036] A further improvement is that: said S7 comprises the following steps:

[0037] S71: Open the inquiry channel, input the inquiry notification letter into the inquiry channel, and directly provide the option of tracing the source of the first-market product information;

[0038] S72: During the drug circulation process, the reference records between each level of enterprises are stored in the archived files;

[0039] S73: Based on the search engine, it provides enterprises with the function of querying records by timestamp.

[0040] A further improvement is that: said S8 comprises the following steps:

[0041] S81: The platform provides manufacturers with the authority to adjust and modify the information of first-time product sales;

[0042] S82: When a manufacturer makes adjustments to the data of its first-time product, the platform will review the adjustments to ensure their accuracy and legality;

[0043] S82: After the review is passed, the first-time product information is updated in the database, and a historical modification record package is generated in a subset of the information to store operation records and provide a timestamp query function for historical information based on a search engine.

[0044] Further improvements are as follows: the electronic information sharing service platform provides a traceability reporting function. After intermediate wholesale enterprises and downstream enterprises obtain the first-time product information and have objections, they can upload their questions and feedback on the information through the traceability reporting function. After the platform reviews the issues, it will be transmitted to the production enterprises for reminder to handle them.

[0045] The beneficial effects of the present invention are:

[0046] 1. The present invention constructs an electronic data sharing service platform. The traceability first-time product data uploaded by the production enterprises can be shared and sent on the platform for traceability. After certification, the intermediate wholesale enterprises and downstream enterprises can obtain the source first-time product data through traceability sharing, which further enhances the authenticity, reliability and accuracy of the first-time product information.

[0047] 2. The present invention reviews the legal qualifications of production enterprises, intermediate wholesale enterprises, and downstream enterprises, and reviews the legality and accuracy of uploaded first-time product information. On the one hand, it realizes the traceability of the legality review of drug circulation varieties and upstream and downstream enterprise information. On the other hand, it helps to achieve comprehensive and dynamic supervision of the circulation industry, improve supervision efficiency, and reduce supervision costs.

[0048] 3. The present invention stores the reference records between enterprises at each level in the archived files, and provides a timestamp query function. It records the production enterprise's adjustment operations on the first-time product information and provides a timestamp query function to facilitate the full-process traceability query of operation records with diversified functions.

[0049] 4. The present invention provides a traceability reporting function, which is convenient for uploading questions and feedback on the first-time product information, reminding the production company to handle it, and the function is more comprehensive. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 It is a flow chart of the present invention. DETAILED DESCRIPTION

[0051] In order to deepen the understanding of the present invention, the present invention will be further described in detail below in conjunction with examples. The examples are only used to explain the present invention and do not constitute a limitation on the protection scope of the present invention.

[0052] Embodiment 1

[0053] according to Figure 1 As shown, this embodiment proposes a method for tracing the source of the first-time electronic data of drugs based on shared transmission, including the following steps:

[0054] S1: Build an electronic data sharing service platform;

[0055] S2: Provide authentication services for manufacturers, intermediate wholesalers, and downstream enterprises to log in for authentication and create files;

[0056] S3: Generate a traceability sharing channel on the production enterprise service page to upload the first-time product information;

[0057] S4: Access the big data search platform and the official website of the drug regulatory agency to review the uploaded first-time product information, which will be displayed in the database of the electronic information sharing service platform after review;

[0058] S5: Intermediate wholesalers and downstream enterprises submit drug information review applications on the platform, and the platform reviews the qualifications of drug demanders and suppliers, as well as the legality of the reviewed drug varieties;

[0059] S6: After the review is passed, the data of the first-time drug products will be shared according to the drug products reviewed, providing a channel for tracing the source for intermediate wholesale enterprises and downstream enterprises;

[0060] S7: Synchronously open the access channel, store the access records between each level of enterprises in the archive, and provide timestamp query function;

[0061] S8: When the manufacturer makes adjustments to the first-time product data, the platform reviews the adjustment operations, stores the operation records in the corresponding first-time product data, and provides a timestamp query function.

[0062] An electronic data sharing service platform is constructed. The traceability first-time product data uploaded by the production enterprise can be shared and sent on the platform for traceability. After certification, the intermediate wholesale enterprises and downstream enterprises can obtain the source of the first-time product data through traceability sharing, which further strengthens the authenticity, reliability and accuracy of the information of the first-time product data. In addition, the present invention reviews the legal qualifications of production enterprises, intermediate wholesale enterprises, and downstream enterprises, and reviews the legality and accuracy of the uploaded first-time product data. On the one hand, it realizes the tracing of the legality review of the drug circulation varieties and the upstream and downstream enterprise data, and on the other hand, it helps to realize the comprehensive dynamic supervision of the circulation industry, improve the supervision efficiency, and reduce the supervision cost.

[0063] Embodiment 2

[0064] according to Figure 1 As shown, this embodiment proposes a method for tracing the source of the first-time electronic data of drugs based on shared transmission, including the following steps:

[0065] Build an electronic information sharing service platform; specifically: use Springboot (rapid service development framework based on spring) + Dubbo (service communication) + Nacos (service registration discovery, configuration management, service governance) + Mybatis Plus (persistence layer framework) to establish server-side feedback, among which, use Java 1.8 as the server-side development language and version, use Maven as the build tool, use Git as the version control tool, use Tapd as the project management tool, use XxlJob as the scheduled task scheduler, use Redis as the remote data structure service, use Alibaba Cloud OCR for text recognition, and use Netcert CA for electronic certification. Use html5+CSS3+TypeScript to build the front-end interface, using vue 3.0 as the web framework, Vue CLI as the building tool, Vue Router to configure page routing, Vuex to manage the status of the electronic data sharing service platform, Element Plus component library to build the user interface, Axios to send asynchronous requests, interact with the back-end service for data, Sass to write more maintainable CSS styles, and ESLint to check the code to ensure code style consistency and quality. Integrate the review channels of drug regulatory units, quality management departments, and centralized pharmaceutical distribution platforms to build login channels for manufacturers, intermediate wholesalers, and downstream companies; build a Mysql database, use the Mysql database to reflect the relationship between data for data interaction; access the search engine, use the ElasticSearch+Logstash+Kibana framework deployment, and use the ElasticSearch search server to complete the distributed multi-user full-text search engine, perform data management, and provide log analysis and visualization platforms.

[0066] Provide certification services for manufacturers, intermediate wholesalers, and downstream companies to log in for authentication and create files; specifically: build a certification review channel on the electronic information sharing service platform, and connect to the review channel of the drug regulatory unit and quality management department; review the legal qualifications of manufacturers, intermediate wholesalers, and downstream companies, and certify them as independent accounts after passing the review; create files based on independent accounts to store a series of circulation records of manufacturers, intermediate wholesalers, and downstream companies.

[0067] A traceability sharing channel is generated on the production enterprise service page for uploading first-time product information; it is used to transmit XML, text, PDF, images and any other format of files, and integrates Big data technology, using distributed fast exchange technology for information transmission. In the process of uploading first-time product information, text data upload and image retrieval upload functions are provided. The image retrieval upload function is based on the TF-IDF statistical document retrieval algorithm, which obtains the visual features of the image through CNN, the sequence features of the image through RNN, and the text sequence information through the classifier CTC or the decoder attention, and extracts the document in the image. Then, based on the document extraction module, the TF-IDF statistical document retrieval algorithm is used to evaluate the importance of multiple words to the document, and extract the keywords of the document as the summary words of the first-time product information. After using TF-IDF to extract features and vectorize the documents, pyLDAvis is used to visualize the first-time product topic clustering of the documents to obtain the visualized clustering results. Then, the initial number of text documents k is selected according to the first-time product topic selection criteria of high similarity within the cluster and low similarity between clusters to obtain the initial model. Then, the correlation between each first-time product t is calculated. The TF-IDF formula is shown in formula (1):

[0068]

[0069] The distribution of feature items among different categories in a category and the position of feature words affect the text discrimination. When a term appears at different positions in a text document, its contribution to discrimination is different. The TF-IDF method is used to calculate the weight of feature words.

[0070] The image text recognition algorithm is as follows:

[0071] CRNN algorithm:

[0072] Algorithm description: CNN+RNN+CTC;

[0073] CNN generally uses VGG16, MobelNet, ResNet34, and ResNet50;

[0074] RNN: generally uses BLSMT / BGRU;

[0075] Classification loss function: CTC.

[0076] Access the big data search platform and the official website of the drug regulatory unit to review the uploaded first-time product information, which will be displayed in the database of the electronic data sharing service platform after review; specifically: access the big data search platform and the official website of the drug regulatory unit, and the platform obtains standard data based on the first-time product; compares the uploaded first-time product information with the standard data to review the legality and accuracy; after the review is passed, it will be displayed in the database of the electronic data sharing service platform, and if it fails, it will be rejected to the production enterprise service page to remind the production enterprise to review and modify it. Intermediate wholesale enterprises and downstream enterprises submit drug information review applications on the platform, and the platform reviews the qualifications of drug demanders and drug suppliers and the legality of the reviewed drug varieties; specifically: the management departments of intermediate wholesale enterprises and downstream enterprises submit drug information review applications on the platform; the quality manager of the corresponding enterprise accesses the platform to review the drug information review application, and uploads the drug information review application to the review department of the platform after the review is passed; the platform conducts a legality review of the drug varieties in the drug information review application, as well as a review of the legal qualifications of the supply unit and drug demander. On the one hand, it can realize the traceability of the legality review of the drug circulation varieties and upstream and downstream enterprise information. On the other hand, it helps to realize the comprehensive dynamic supervision of the circulation industry, improve the supervision efficiency and reduce the supervision cost.

[0077] After the review is passed, the data of the first-time products will be shared according to the types of drugs reviewed, and the intermediate wholesalers and downstream companies will be given a channel for tracing the source. Specifically, after the review is passed, the review notice letter will be sent to the supplier, and a template for signing a quality assurance agreement will be provided. Then, according to the types of drugs reviewed, the data of the first-time products will be shared, and the intermediate wholesalers and downstream companies will be given a channel for querying. The intermediate wholesalers and downstream companies will be shielded from querying the modification and adjustment of the data of the first-time products. This makes the data of the first-time products unique from upstream to downstream, improving its accuracy.

[0078] Synchronously open the access channel, store the access records between each level of enterprises in the archived files, and provide the timestamp query function; specifically: open the access channel, input the access notice letter into the access channel, and directly provide the option of tracing the source of the first-market product information; in the process of drug circulation, store the access records between each level of enterprises in the archived files; based on the search engine, provide enterprises with the function of querying records by timestamp. The query transmission protocols include tcp, ftp, syslog, http, pop3, smtp, telnet, and ip-mac protocols.

[0079] During the process of the production enterprise adjusting the first-time product information, including modification, writing, copying, deleting, creating, reading, overwriting, moving, and renaming, the platform audits the adjustment operation, stores the operation record in the corresponding first-time product information, and provides a timestamp query function. Specifically: the platform provides the production enterprise with the authority to adjust and modify the first-time product information; when the production enterprise adjusts the first-time product information, the platform audits the adjustment operation to ensure its accuracy and legality; after the audit is passed, the first-time product information is updated in the database, and a historical modification record package is generated in the subset of the information to store operation records, and based on the search engine, a timestamp query function for historical data is provided. Provide a basis for responsibility identification and investigation for illegal operations, misoperations, breaches of confidentiality, theft of secrets, tampering, deletion, and changes to files under designated paths.

[0080] The electronic data sharing service platform provides a traceability reporting function. After the intermediate wholesalers and downstream enterprises obtain the first-time product data and have objections, they can upload their questions and feedback on the data through the traceability reporting function. After the platform reviews the issues, it will be transmitted to the production enterprises to remind them to handle them. Providing a traceability reporting function facilitates uploading questions and feedback on the first-time product data and reminds the production enterprises to handle them. The function is more comprehensive.

[0081] Verification Example

[0082] After the platform was launched, the time required to exchange first-time business information was shortened from 3-7 days to 2-3 minutes; the exchange cost was reduced from 10-15 yuan per copy to zero cost; and the clarity and quality of first-time business information were greatly improved.

[0083] The present invention constructs an electronic data sharing service platform. The traceability first-time product data uploaded by the production enterprise can be traced and shared on the platform. After the intermediate wholesale enterprises and downstream enterprises are authenticated, they can obtain the source of the first-time product data through traceability sharing, which further enhances the authenticity, reliability and accuracy of the information of the first-time product data. In addition, the present invention reviews the legal qualifications of the production enterprises, intermediate wholesale enterprises, and downstream enterprises, and reviews the legality and accuracy of the uploaded first-time product data. On the one hand, it realizes the tracing of the legality review of the drug circulation varieties and the upstream and downstream enterprise data, and on the other hand, it helps to realize the comprehensive dynamic supervision of the circulation industry, improve the supervision efficiency, and reduce the supervision cost. At the same time, the present invention stores the reference records between each level of enterprises in the archived files, and provides a timestamp query function, records the adjustment operations of the production enterprises on the first-time product data, and provides a timestamp query function, which is convenient for realizing the full-process traceability query of the operation records, and the functions are diversified. In addition, the present invention provides a traceability reporting function, which is convenient for uploading questions and feedback on the first-time product data, reminding the production enterprises to handle, and the functions are more comprehensive.

[0084] The above shows and describes the basic principles, main features and advantages of the present invention. It should be understood by those skilled in the art that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention. The scope of protection of the present invention is defined by the attached claims and their equivalents.

Claims

1. A method for tracing the origin of electronic data of first-time drug sales based on shared transmission, characterized in that: The following steps are involved: S1: Constructing an electronic data sharing service platform, including the following steps: S11: Springboot+Dubbo+Nacos+Mybatis Plus is used to establish server-side feedback. Java 1.8 is used as the server-side development language and version, Maven is used as the build tool, Git is used as the version control tool, Tapd is used as the project management tool, XxlJob is used as the scheduled task scheduler, Redis is used as the remote data structure service, Alibaba Cloud OCR is used for text recognition, and NetCert CA is used for electronic certification; S12: Use HTML5+CSS3+TypeScript to build the front-end interface, using Vue 3.0 as the web framework, Vue CLI as the building tool, Vue Router to configure page routing, Vuex to manage the status of the electronic data sharing service platform, Element Plus component library to build the user interface, Axios to send asynchronous requests, Sass to write CSS styles, and ESLint to check the code for specifications; S13: Integrate the review channels of drug regulatory units, quality management departments, and centralized pharmaceutical distribution platforms to build login channels for manufacturers, intermediate wholesalers, and downstream companies; S14: Build a MySQL database, and use the MySQL database to reflect the relationship between data for data interaction; S15: Access to search engines, deployed using the ElasticSearch+Logstash+Kibana framework, using the ElasticSearch search server to complete a distributed multi-user full-text search engine, perform data management, and provide log analysis and visualization platforms; S2: Provide certification services for manufacturers, intermediate wholesalers, and downstream enterprises to log in for certification and create files, including the following steps: S21: Build a certification review channel on the electronic data sharing service platform and connect to the review channels of drug regulatory units and quality management departments; S22: Review the legal qualifications of production enterprises, intermediate wholesale enterprises, and downstream enterprises, and certify them as independent accounts after passing the review; S23: Create files based on independent accounts to store a series of circulation records of production enterprises, intermediate wholesale enterprises, and downstream enterprises; S3: Generate a traceability sharing channel on the production enterprise service page for uploading the first-time product information. In the process of uploading the first-time product information, text data uploading and image retrieval uploading functions are provided. The image retrieval uploading function is based on the TF-IDF statistical document retrieval algorithm. It obtains the visual features of the image through CNN, obtains the sequence features of the image through RNN, obtains the text sequence information through the classifier CTC or the decoder attention, extracts the document in the image, and then uses the TF-IDF statistical document retrieval algorithm based on the document extraction module to evaluate the importance of multiple words to the document, extract the keywords of the document as the summary words of the first-time product information; S4: Access the big data search platform and the official website of the drug regulatory agency to review the uploaded first-time product information, which will be displayed in the database of the electronic information sharing service platform after review, including the following steps: S41: Access to the big data search platform and the official website of the drug regulatory agency, and the platform obtains standard data based on the first-marketed product; S42: Compare the uploaded first-time product data with standard data to review the legality and accuracy; S43: After the review is passed, it will be displayed in the database of the electronic data sharing service platform. If it fails to pass the review, it will be rejected to the production enterprise service page, reminding the production enterprise to make revisions to the review; S5: Intermediate wholesalers and downstream enterprises submit drug information review applications on the platform, and the platform reviews the qualifications of drug demanders and suppliers, as well as the legality of the reviewed drug varieties; S6: After the review is passed, the data of the first-time drug products will be shared according to the drug products reviewed, providing a channel for tracing the source for intermediate wholesale enterprises and downstream enterprises; S7: Synchronously open the access channel, store the access records between each level of enterprises in the archive, and provide timestamp query function; S8: When the manufacturer makes adjustments to the first-time product data, the platform reviews the adjustment operations, stores the operation records in the corresponding first-time product data, and provides a timestamp query function.

2. The method for tracing the source of electronic data of the first sale of drugs based on shared transmission according to claim 1 is characterized by: The S5 comprises the following steps: S51: The management departments of the intermediate wholesale enterprises and downstream enterprises submit drug information access applications on the platform; S52: The quality manager of the corresponding enterprise accesses the platform to review the drug information review application, and uploads the drug information review application to the review department of the platform after passing the review; S53: The platform conducts a legality review on the types of drug information review applications, as well as a review on the legal qualifications of suppliers and drug demanders.

3. The method for tracing the source of electronic data of the first sale of drugs based on shared transmission according to claim 2 is characterized by: The S6 comprises the following steps: S61: After the review is passed, a review notice letter will be sent to the supplier, and a quality assurance agreement signing template will be provided; S62: Then, according to the drug varieties consulted, the data sharing of first-time drug varieties is opened, providing a channel for query by intermediate wholesale enterprises and downstream enterprises; S63: Block the authority of intermediate wholesale enterprises and downstream enterprises to modify and adjust the information of first-selling products.

4. The method for tracing the source of electronic data of the first sale of drugs based on shared transmission according to claim 3 is characterized by: The S7 comprises the following steps: S71: Open the inquiry channel and input the downloaded inquiry notification letter into the inquiry channel. The inquiry channel directly provides the option of tracing the source of the first-market product information; S72: During the drug circulation process, the reference records between each level of enterprises are stored in the archived files; S73: Based on the search engine, it provides enterprises with the function of querying records by timestamp.

5. The method for tracing the source of electronic data of the first sale of drugs based on shared transmission according to claim 4 is characterized by: The S8 comprises the following steps: S81: The platform provides manufacturers with the authority to adjust and modify the information of first-time product sales; S82: When a manufacturer makes adjustments to the data of a first-time product, the platform will review the adjustment to ensure its accuracy and legality; S82: After the review is passed, the first-time product information is updated in the database, and a historical modification record package is generated in a subset of the information to store operation records and provide a timestamp query function for historical information based on a search engine.

6. The method for tracing the source of electronic data of the first sale of drugs based on shared transmission according to any one of claims 1 to 5, characterized in that: The electronic information sharing service platform provides a traceability reporting function. After intermediate wholesalers and downstream companies obtain the first-time product information and have objections, they can upload their questions and feedback about the information through the traceability reporting function. After reviewing the issues, the platform will transmit them to the production companies to remind them to handle them.

Images